Wayne Hurst, DPM
Podiatrist · Cedar Park, TXNPI 1194758482
Payments from drug & device makers
What this record shows
This record is dominated by other: $598,319 of the $625,225 with a category attached, or 95.7%. Linvatec Corporation accounts for 96.4% of it on its own, with 50 other manufacturers making up the rest. Reporting peaked in 2022 at $532,968 and has fallen 99.7% since, to $1,436 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $1731.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$603K
- In2bones USA, LLC$6K
- Stryker$5K
- Arthrex$2K
- Nevro Corp.$2K
- Nvision Biomedical Technologies, Inc.$977
- plus $8K from 45 others
What the payments were for
- Royalty or licence$4,7131%
- Consulting fees$1,7000%
- Speaking & faculty fees$4,0121%
- Grants$1,0000%
- Travel & lodging$4,2331%
- Food & beverage$9,5042%
- Education$1,7440%
- Other$598,31996%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$598,319
- CoLink$4,548
- FRACTURE AND CORRECTION COLAG 2$4,140
- COLINK PLATING SYSTEM$4,140
- CoLag$4,048
- LMH$3,448
- PitStop$1,159
- AlloAid Allograft$1,000
- Senza$940
- TENFUSE$906
- Lapiplasty System$602
- Suture Anchor$552
- Omnia$426
- Foot and Ankle$266
- PROCLAIM$266
- Reference Toe System$159
- CITREFIX$156
- Dynasplint$133
- Proclaim IPG$129
- VHT-200 Wound Treatment System$128
How this compares
$625,225 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 53 | $2,409 |
| Terbinafine Hcl | 28 | $438 |
| Pregabalin | 14 | $251 |
| Allopurinol | 15 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $180 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $137 |
| Cephalexin | 24 | $102 |
| Promethazine Hcl | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Cedar Park
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
- Binoy ShethAllen$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.